povidone-iodine has been researched along with Skin-Diseases--Bacterial* in 3 studies
1 review(s) available for povidone-iodine and Skin-Diseases--Bacterial
Article | Year |
---|---|
[Antiseptics in skin diseases].
Topics: Anti-Infective Agents, Local; Antisepsis; Benzalkonium Compounds; Chlorhexidine; Humans; Povidone-Iodine; Skin; Skin Diseases; Skin Diseases, Bacterial | 1996 |
1 trial(s) available for povidone-iodine and Skin-Diseases--Bacterial
Article | Year |
---|---|
Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
Local skin antiseptic prevention against cardiac implantable electronic device (CIED) infections is not yet fully understood. This monocentre historical-controlled study sought to (i) conduct a prospective observational analysis comparing two antiseptic skin preparations over two similar consecutive periods of time, one conducted over a 1-year period using an aqueous povidone-iodine solution (Group I) and the other over the following with an alcoholic povidone-iodine solution (Group II); (ii) determine the predictive factors of CIED infection.. Cardiac implantable electronic device implantation was performed in 1326 patients (pts). A total of 32 pts (2.4%) developed a CIED infection. Long-term follow-up (26 ± 3 months) revealed no significant difference between the groups: infections were observed in 14 of the 648 pts (2.2%) in Group I vs. 18 of the 678 pts (2.7%) in Group II (P = 0.9). Single- and multiple-variable logistic regression analyses were performed to identify risk factors; adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated. The occurrence of infection was positively correlated with re-intervention (aOR, 7.16; 95% CI, 2.56-19.99; P < 0.0001), number of generator replacements, mean (aOR, 3.47; 95% CI, 2.22-5.44; P < 0.001), and haematoma (aOR, 48.4; 95% CI, 13.45-174.25; P < 0.0001).. This study found that aqueous and alcoholic povidone-iodine solutions displayed similar antiseptic effects regarding CIED infection prevention. Independent predictive factors of CIED infection were re-intervention, haematoma, and number of generator replacements. Topics: Administration, Cutaneous; Aged; Antibiotic Prophylaxis; Defibrillators, Implantable; Ethanol; Female; Humans; Male; Pacemaker, Artificial; Povidone-Iodine; Prosthesis-Related Infections; Skin Diseases, Bacterial; Treatment Outcome; Water | 2015 |
1 other study(ies) available for povidone-iodine and Skin-Diseases--Bacterial
Article | Year |
---|---|
Antiseptic efficacy of local disinfecting povidone-iodine (Betadine) therapy in chronic wounds of lymphedematous patients.
In chronic wounds (ulcus cruris) of lymphedematous patients (n = 25) opportunistic infections caused by gram-negative rods and methicillin-resistant Staphylococcus aureus can be detected in 35% of cases. The healing of the wound takes a long time, which is the reason why the patients are taught how to manage the wound care. Local antibiotics must be avoided. The elimination of the wound infections is the first step of the complex decongestive physiotherapy. The infection aggravates the lymphostasis and makes the complaints of the patients (inflammation, pain, odor) more unacceptable, the systemic infections (erysipelas, lymphadenopathy, fever) more probable and the costs of the treatment higher. Betadine solution and ointment were used locally. The clinical and bacteriological efficacy of povidone-iodine has been validated. Excellent local tolerability has also been observed. The opinion of the patients was registered on a visual analog scale and statistically analyzed. No development of resistance has been noted. For local treatment, Betadine proved to be an effective preparation tolerable for a long time in the treatment of chronic wounds. Topics: Adult; Anti-Infective Agents, Local; Chronic Disease; Female; Humans; Leg Ulcer; Lymphedema; Male; Middle Aged; Povidone-Iodine; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus | 2002 |